PGC-1α and reactive oxygen species regulate human embryonic stem cell-derived cardiomyocyte function.

Area of Science:

• Biochemistry
• Cardiology
• Stem Cell Biology

Background:

• Mitochondrial dysfunction is linked to heart disease.
• PGC-1α is crucial for mitochondrial gene expression in cardiomyocytes.

Purpose of the Study:

• To investigate the role of PGC-1α in cardiomyocyte function using a human disease model.
• To explore the relationship between PGC-1α, mitochondrial activity, and reactive oxygen species (ROS).

Main Methods:

• Developed a human disease model using cardiomyocytes derived from human embryonic stem cells (hESCs).
• Inactivated a key mitochondrial gene expression pathway by repressing PGC-1α.
• Measured mitochondrial content, activity, ROS levels, action potential, and calcium transients.

Main Results:

• Repressing PGC-1α decreased mitochondrial content and activity, impairing energetic stress response.
• Concurrently, reactive oxygen species (ROS) levels were reduced.
• Lowering ROS in control cells mimicked PGC-1α repression effects, increasing calcium transient amplitude.

Conclusions:

• Controlling ROS levels is critical for achieving mature cardiomyocyte phenotypes.
• The developed hESC-derived cardiomyocyte model and bioassays are valuable for studying cardiac physiology and disease.
• Targeting ROS may offer therapeutic strategies for heart diseases linked to mitochondrial dysfunction.